These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7002690)

  • 1. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell.
    Kawamori R; Shichiri M; Kikuchi M; Yamasaki Y; Abe H
    Diabetes; 1980 Sep; 29(9):762-5. PubMed ID: 7002690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
    Shichiri M; Kawamori R; Abe H
    Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of exaggerated glucagon response to arginine in diabetes mellitus.
    Kawamori R; Shichiri M; Kikuchi M; Yamasaki Y; Abe H
    Diabetes Res Clin Pract; 1985 Oct; 1(3):131-7. PubMed ID: 3915260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
    Hamaguchi T; Fukushima H; Uehara M; Wada S; Shirotani T; Kishikawa H; Ichinose K; Yamaguchi K; Shichiri M
    Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man.
    Hanna AK; Zinman B; Nakhooda AF; Minuk HL; Stokes EF; Albisser AM; Leibel BS; Marliss EB
    Metabolism; 1980 Apr; 29(4):321-32. PubMed ID: 6990172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.
    Ward WK; Bolgiano DC; McKnight B; Halter JB; Porte D
    J Clin Invest; 1984 Oct; 74(4):1318-28. PubMed ID: 6384269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of the blunted glucagon response to insulin-induced hypoglycemia in diabetics].
    Katsura M
    Nihon Naibunpi Gakkai Zasshi; 1986 Nov; 62(11):1276-88. PubMed ID: 3542595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose modulation of insulin and glucagon secretion in nondiabetic and diabetic man.
    Hollander PM; Asplin CM; Palmer JP
    Diabetes; 1982 Jun; 31(6 Pt 1):489-95. PubMed ID: 6759265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and glucagon secretion in diabetic and non-diabetic patients with circulating islet cell antibodies.
    Tiengo A; Del Prete GF; Nosadini R; Betterle C; Garotti C; Bersani G
    Diabetologia; 1977 Sep; 13(5):451-8. PubMed ID: 332569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cholinergic regulation of insulin and glucagon secretion in healthy people and in patients with non-insulin dependent diabetes].
    Czyźyk A; Lawecki J; Strycek-Kaminska D
    Z Gesamte Inn Med; 1981 Jan; 36(2):43-7. PubMed ID: 7013296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normalization of fasting hyperglucagonemia and excessive glucagon responses to intravenous arginine in human diabetes mellitus by prolonged infusion of insulin.
    Gerich JE; Tsalikian E; Lorenzi M; Schneider V; Bohannon NV; Gustafson G; Karam JH
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1178-80. PubMed ID: 1206104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation induced by a three-days application of the artificial beta-cell on glucagon, growth hormone and catecholamine secretion, glycosylated hemoglobin, and erythrocyte 2,3-diphosphoglycerate concentration.
    Brunetti P; Massi-Benedetti M; Puxeddu A; Santeusanio F; Calabrese G; Bolli G; Scionti L; Angeletti G
    Horm Metab Res Suppl; 1979; (8):81-6. PubMed ID: 395095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects.
    Prince RL; Larkins RG; Alford FP
    Metabolism; 1981 Mar; 30(3):293-8. PubMed ID: 7010074
    [No Abstract]   [Full Text] [Related]  

  • 16. An 'artificial beta cell' for control of diabetes mellitus: effect on plasma glucagon levels.
    Horwitz DL; Gonen B; Jaspan JB; Langer BG; Rodman D; Zeidler A
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):639-44. PubMed ID: 394885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of insulin secretion in diabetes mellitus.
    Ward WK; Beard JC; Halter JB; Porte D
    Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
    Waldhäusl W; Bratusch-Marrain P; Nowotny P
    Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.